icosabutate
Small moleculeexperimental
Clinical trial activity
7 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT01893515)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CC)C(=O)O- Mol. weight
- 374.57 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707220 ↗
Also known as
- icosabutate
- icosabutate
- icosabutate
- icosabutate
- prb-01022
- prb-01022
- prc-4016
- prc-4016
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04052516 | Phase 2 | Jul 17, 2019 | NorthSea Therapeutics B.V. |
| NCT03577275 | Phase 1 | Jun 15, 2018 | NorthSea Therapeutics B.V. |
| NCT02364635 | Phase 1 | Feb 1, 2015 | Covance, Pronova BioPharma |
| NCT02367937 | Phase 1 | Aug 1, 2014 | Covance, Pronova BioPharma |
| NCT02373176 | Phase 1 | Jul 1, 2014 | Covance, Pronova BioPharma |
| NCT01972178 | Phase 2 | Nov 1, 2013 | Pronova BioPharma |
| NCT01893515 | Phase 2 | Jul 1, 2013 | Pronova BioPharma |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pronova BioPharma | For profit | 5 | 5 | 2 | 2013 |
| Covance | For profit | 3 | 0 | 1 | 2014 |
| NorthSea Therapeutics B.V. | For profit | 2 | 2 | 2 | 2018 |
3 organizations
Page 1 / 1